Master of Science in Interdisciplinary Oncology (MSc)

Overview

The Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology. Those fields include: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, molecular pathology, sociobehavioral studies, epidemiology and health economics. The goal of the program is to provide graduate students from diverse backgrounds, with an education in a number of disciplines relating to oncology, and to provide training opportunities for intensive training in specialized aspects of cancer research. For more than ten years, the program has been training the next generation of cancer research leaders.

 

 

What makes the program unique?

IOP integrates the diverse areas of oncology by offering two required courses which provide an interdisciplinary perspective on oncology in a form that is accessible to students from diverse backgrounds. The elective courses provide intensive training in one or more subjects specific to the student's research, and also gives the student an opportunity to gain expertise in other disciplines that have potential for synergy with their primary specialization. Students have access to clinicians and university faculty through the world-renowned BC Cancer Agency, to get a practical perspective on oncology treatments and outcomes. An innovative rotation course is a unique option for students to gain hands-on experience by rotating through specialty laboratories and by shadowing clinicians. 

Quick Facts

Degree
Master of Science
Subject
Health and Medicine
Mode of delivery
On campus
Specialization
Interdisciplinary Oncology
Program Components
Coursework + Thesis required
Faculty
Faculty of Medicine

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Program Enquiries

If you have reviewed the information on this program page and understand the requirements for this program, you may send an enquiry

Research Information

Program Components

Once students are enrolled in the program, they will have an opportunity to design a program that allows for rotations through other IOP faculty's labs to gain insight into other research areas other than their specific supervisor's research.

Research Facilities

Most IOP supervisors reside off-campus at the BC Cancer Research Centre, the Prostate Centre at Vancouver General Hospital or other hospital-related buildings.

Application Notes

Students must secure a supervisor before they can be admitted into the program. As well, they must meet the minimum admission requirements set out by Graduate and Post-doctoral Studies at UBC.

Requirements

Document Requirements

CV, Official transcripts, three letters of reference, Official English exam scores (if required)

TOEFL (ibT) Overall Score Requirement

100
22
24
22
22

IELTS Overall Score Requirement

7.0
6.0
6.0
6.0
6.0

Supervisor commitment required prior to application?

Yes

Prior degree requirements

A B.Sc is the minimum requirement.

Deadline Details

Application Deadline

Deadline to submit online application. No changes can be made to the application after submission.

Transcript Deadline

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Referee Deadline

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

January 2020 Intake

Application Open Date
19 June 2019
Canadian Applicants
Application Deadline: 10 September 2019
Transcript Deadline: 10 September 2019
Referee Deadline: 10 September 2019
International Applicants
Application Deadline: 07 August 2019
Transcript Deadline: 07 August 2019
Referee Deadline: 07 August 2019

May 2020 Intake

Application Open Date
20 June 2019
Canadian Applicants
Application Deadline: 09 January 2020
Transcript Deadline: 09 January 2020
Referee Deadline: 09 January 2020
International Applicants
Application Deadline: 30 November 2019
Transcript Deadline: 30 November 2019
Referee Deadline: 30 November 2019

September 2020 Intake

Application Open Date
21 June 2019
Canadian Applicants
Application Deadline: 23 April 2020
Transcript Deadline: 23 April 2020
Referee Deadline: 23 April 2020
International Applicants
Application Deadline: 30 March 2020
Transcript Deadline: 30 March 2020
Referee Deadline: 30 March 2020

Funding Sources

All students who secure a supervisor and who are enrolled in the program will be paid a minimum stipend of $24,300/year.

Career Options

Graduates have a wide range of options from working in government institutions to academia to biotechnology and bio-pharm companies. Those looking to further their academic career have entered medical school or are pursuing a Ph.D. degree in Canada and abroad.

Tuition / Program Costs

FeesCanadian Citizen / Permanent Resident / Refugee / DiplomatInternational
Application Fee$104.00$168.25
Tuition *
Installments per year33
Tuition per installment$1,665.26$2,925.58
Tuition per year
(plus annual increase, usually 2%-5%)
$4,995.78$8,776.74
Int. Tuition Award (ITA) per year (if eligible) $3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)$930.14 (approx.)
Costs of living (yearly)starting at $16,884.10 (check cost calculator)
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Statistical Data

Enrolment Data

 20182017201620152014
Applications2528151614
Offers10101287
New registrations991076
Total enrolment2323231416

Completion Rates & Times

This program has a graduation rate of 76.92% based on 13 students admitted between 2009 - 2012. Based on 10 graduations between 2015 - 2018 the minimum time to completion is 2.33 years and the maximum time is 5.33 years with an average of 3.20 years of study. All calculations exclude leave times.
Disclaimer
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 22 March 2019]. Enrolment data are based on March 1 snapshots. Program completion data are only provided for datasets comprised of more than 4 individuals. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs [data updated: 27 October 2019].

Research Supervisors

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

  • Aparicio, Samuel (Breast cancer, genome sequencing )
  • Bally, Marcel Bertran (Pancreas centre)
  • Baumbusch, Jennifer (long-term residential care, family caregiving, Intellectual Disability, nursing care of older adults )
  • Benard, Francois (Medical isotopes Radioisotopes Nuclear Medicine Cancer Imaging Molecular imaging of cancer Radionuclide therapy, Cancer division, radiology, pancreas centre)
  • Bennewith, Kevin (Oncology; Molecular Pathology & Cell Biology; Cancer research; Solid tumour microenvironment; Hypoxia; Metastasis research; Pre-metastatic niche; Targeting hypoxic tumour cells in therapy; Radiation biology)
  • Brooks-Wilson, Angela (human genetics, cancer genetics, cancer families, longevity, Super seniors, genetic susceptibility)
  • Brown, Carolyn Janet (Epigenetic control of gene expression, X-chromosome inactivation, Long non-coding RNAs, XIST RNA, Genes escaping X-chromosome inactivation, DNA methylation)
  • Burgess, Michael (Public deliberation, Health Policy, Science Policy, Deliberative Democracy)
  • Buttyan, Ralph (Kidneys, Urinary System, Benign Bladder Dysfunctions)
  • Campbell, Kristin (exercise physiology, physical function, oncology, biomarkers)
  • Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
  • Daugaard, Mads (Cancer biology, Glycobiology, DNA damage response pathways, Cancer therapy, Cancer diagnostics, Stress signalling in cancer, Immunotherapy)
  • Dedhar, Shoukat (molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation)
  • Eaves, Constance Jean (Normal and leukemic stem cells, normal and malignant breast stem cells)
  • Garnis, Catherine (Cancer biology; Tumor progression; Oral premalignant lesions; Head and neck cancer; RNA biology, microRNAs; Alternative splicing; Biomarkers)
  • Gleave, Martin (Infectious diseases, interdisciplinary oncology, prostate)
  • Guns, Emma (pharmacology, ADMET, drug discovery, mass spectrometry, natural products, cancer cell biology, steroidogenesis in oncology, hormone receptor targeting and pathway analysis (pharmacodynamics), extracellular vesicles in cancer cell communication)
  • Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
  • Hirst, Martin (Epigenomics)
  • Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
  • Howard, Fuchsia (health service needs of vulnerable, high-risk survivors of acute life-threatening illness, specifically, cancer survivors and survivors of critical illnesses; hereditary cancer prevention and risk management and psychosocial and ethnocultural factors that shape health and illness experiences)
  • Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
  • Jiang, Xiaoyan (Basic and translational leukemia research, Leukemic stem cell biology , Gene regulation , Drug resistance , Proteomics, Immunotherapy)

Pages

Further Program Information

 

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
 

January 2020 Intake

Application Open Date
19 June 2019
Canadian Applicant Deadline
10 September 2019
International Applicant Deadline
07 August 2019

May 2020 Intake

Application Open Date
20 June 2019
Canadian Applicant Deadline
09 January 2020
International Applicant Deadline
30 November 2019

September 2020 Intake

Application Open Date
21 June 2019
Canadian Applicant Deadline
23 April 2020
International Applicant Deadline
30 March 2020
 

Supervisor Search

 

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update the application inquiries contact details please use this form.